Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Perphenazine
Drug ID BADD_D01743
Description An antipsychotic phenothiazine derivative with actions and uses similar to those of chlorpromazine.
Indications and Usage For use in the management of the manifestations of psychotic disorders and for the control of severe nausea and vomiting in adults.
Marketing Status Prescription; Discontinued
ATC Code N05AB03
DrugBank ID DB00850
KEGG ID D00503
MeSH ID D010546
PubChem ID 4748
TTD Drug ID D02HED
NDC Product Code 70518-3033; 70518-0940; 52536-164; 70518-1125; 0591-4103; 0591-4102; 0781-8046; 0591-4104; 63629-2251; 70518-0710; 0781-8047; 0603-5062; 68084-602; 63629-2250; 52536-168; 0781-8048; 68382-594; 70518-2639; 0603-5060; 70518-2985; 0904-6600; 64980-293; 65372-1191; 70771-1043; 68084-607; 52536-170; 70518-3018; 0603-5061; 70518-2890; 0904-6601; 63629-2248; 0591-4101; 64980-292; 70518-0458; 0603-5063; 70518-0731; 63629-2253; 70771-1044; 68382-592; 70518-3108; 70518-3106; 70518-1109; 70771-1041; 63629-2252; 70518-3257; 64980-290; 70518-1739; 68382-591; 63629-2249; 46204-0003; 70518-3121; 63629-7252; 52536-162; 68382-593; 53808-1124; 0781-8049; 42973-165; 64980-291; 70518-1133; 70771-1042; 0904-6599
Synonyms Perphenazine | Perfenazine | Chlorpiprazine | Trilafon
Chemical Information
Molecular Formula C21H26ClN3OS
CAS Registry Number 58-39-9
SMILES C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abnormal dreams19.02.03.001; 17.15.02.001--Not Available
Agitation19.06.02.001; 17.02.05.012--
Agranulocytosis01.02.03.001--Not Available
Akathisia19.06.02.006; 17.01.02.002--
Amenorrhoea21.01.02.001; 05.05.01.002--
Anaphylactic shock10.01.07.002; 24.06.02.004--Not Available
Anaphylactoid reaction24.06.03.007; 10.01.07.003--Not Available
Angioedema23.04.01.001; 10.01.05.009--Not Available
Asphyxia22.02.02.001; 12.01.08.011--Not Available
Asthma10.01.03.010; 22.03.01.002--Not Available
Ataxia17.02.02.001; 08.01.02.004--
Body temperature increased13.15.01.001--Not Available
Bradycardia02.03.02.002--Not Available
Breast enlargement21.05.04.001--Not Available
Cardiac arrest02.03.04.001--
Catatonia19.11.01.001--Not Available
Cholestasis09.01.01.001--Not Available
Circulatory collapse24.06.02.001--Not Available
Confusional state19.13.01.001; 17.02.03.005--
Constipation07.02.02.001--
Cough22.02.03.001--
CSF protein abnormal13.07.02.004--Not Available
Death08.04.01.001--
Dermatitis contact12.03.01.040; 10.01.01.003; 23.03.04.004--Not Available
Dermatitis exfoliative23.03.07.001; 10.01.01.004--
Diarrhoea07.02.01.001--
Dizziness24.06.02.007; 17.02.05.003; 02.01.02.004--
Dry mouth07.06.01.002--
Dysarthria19.19.03.001; 17.02.08.001--
Dyskinesia17.01.02.006--
The 1th Page    1 2 3 4 5    Next   Last    Total 5 Pages